Phaseline

Targets › GHSR

GHSR (Growth hormone secretagogue receptor type 1): drug programs, companies and trials

1 program from 1 company in 2 trials: 2 Phase 2; Oncology; next expected readout Dec 2026.

G protein-coupled receptor specific to ghrelin, an appetite-regulating peptide hormone commonly found in stomach. Upon activation, stimulates appetite and promotes growth hormone secretion. (UniProt, Q92847)

Open in Phaseline: the race on GHSR, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
M.D. Anderson Cancer CenterAnamorelin Hydrochloride
Ghrelin receptor agonist
GHSRPhase 2Anorexia; Advanced Malignant Solid NeoplasmDec 2026

Conditions

Anorexia (1) Advanced Malignant Solid Neoplasm (1)

Modalities

small molecule (1)

Companies

M.D. Anderson Cancer Center (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.